phase 3 trial
Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
October 6, 2026Diabetes, GLP-1, Obesity, diabetes, obesity, phase 3 trial
Boehringer Ingelheim’s investigational survodutide produced weight loss of up to 13.1% after 76 weeks in people with obesity or overweight …
Ondine reports 40% reduction in surgical-site infections in phase 3 trial
September 9, 2026Ondine Biomedical, nasal photodisinfection technology, phase 3 trial, surgical-site infections
Ondine Biomedical has reported a 40% relative reduction in 30-day surgical-site infections (SSIs) in a 5,188-patient phase 3 trial of …
Genentech shares data from phase 3 trials of Vabysmo for retinal vein occlusion treatment
October 10, 2023Research and Development Genentech, Opthalmology, Vabysmo, phase 3 trial, retinal vein occlusion
Genentech has announced positive topline long-term results from its global phase 3 BALATON and COMINO trials which assessed extended treatment …
CytoDyn’s COVID-19 treatment shows positive results in Phase III trial
March 9, 2021Manufacturing and Production cytodyn, phase 3 trial, vyrologix
Biotechnology company CytoDyn has shown positive results in its Phase III CD12 trial of Vyrologix, its treatment for COVID-19 patients …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
